TGF0bzo3MDAjIyNQb3BwaW5zOjMwMA==
IGgyLnRiLWhlYWRpbmdbZGF0YS10b29sc2V0LWJsb2Nrcy1oZWFkaW5nPSJlZTJkYzlhMTBiZWY2NjNkZGE1NWRmNWM4MTk4M2U5MyJdICB7IGZvbnQtc2l6ZTogMzJweDtmb250LWZhbWlseTogUG9wcGlucztmb250LXdlaWdodDogMzAwO2NvbG9yOiByZ2JhKCA0NSwgODQsIDExMSwgMSApO3RleHQtYWxpZ246IGxlZnQ7IH0gIC50Yi1maWVsZFtkYXRhLXRvb2xzZXQtYmxvY2tzLWZpZWxkPSIxZWQ0NzZkYjNmNTU2MWIwYzY2ZjM2NmJmMDJlYmJhOSJdIHsgZm9udC1zaXplOiAxN3B4O2ZvbnQtZmFtaWx5OiBMYXRvO2ZvbnQtd2VpZ2h0OiA3MDA7Y29sb3I6IHJnYmEoIDczLCA3MywgNzMsIDEgKTsgfSAgLnRiLWltYWdle3Bvc2l0aW9uOnJlbGF0aXZlO3RyYW5zaXRpb246dHJhbnNmb3JtIDAuMjVzIGVhc2V9LndwLWJsb2NrLWltYWdlIC50Yi1pbWFnZS5hbGlnbmNlbnRlcnttYXJnaW4tbGVmdDphdXRvO21hcmdpbi1yaWdodDphdXRvfS50Yi1pbWFnZSBpbWd7bWF4LXdpZHRoOjEwMCU7aGVpZ2h0OmF1dG87d2lkdGg6YXV0bzt0cmFuc2l0aW9uOnRyYW5zZm9ybSAwLjI1cyBlYXNlfS50Yi1pbWFnZSAudGItaW1hZ2UtY2FwdGlvbi1maXQtdG8taW1hZ2V7ZGlzcGxheTp0YWJsZX0udGItaW1hZ2UgLnRiLWltYWdlLWNhcHRpb24tZml0LXRvLWltYWdlIC50Yi1pbWFnZS1jYXB0aW9ue2Rpc3BsYXk6dGFibGUtY2FwdGlvbjtjYXB0aW9uLXNpZGU6Ym90dG9tfSAud3AtYmxvY2staW1hZ2UudGItaW1hZ2VbZGF0YS10b29sc2V0LWJsb2Nrcy1pbWFnZT0iNjdmZTU1MzUxOGNkNjMwODk3N2E5OWMxNjQ5MTllNzAiXSB7IG1heC13aWR0aDogMTAwJTsgfSBAbWVkaWEgb25seSBzY3JlZW4gYW5kIChtYXgtd2lkdGg6IDc4MXB4KSB7ICAgIC50Yi1pbWFnZXtwb3NpdGlvbjpyZWxhdGl2ZTt0cmFuc2l0aW9uOnRyYW5zZm9ybSAwLjI1cyBlYXNlfS53cC1ibG9jay1pbWFnZSAudGItaW1hZ2UuYWxpZ25jZW50ZXJ7bWFyZ2luLWxlZnQ6YXV0bzttYXJnaW4tcmlnaHQ6YXV0b30udGItaW1hZ2UgaW1ne21heC13aWR0aDoxMDAlO2hlaWdodDphdXRvO3dpZHRoOmF1dG87dHJhbnNpdGlvbjp0cmFuc2Zvcm0gMC4yNXMgZWFzZX0udGItaW1hZ2UgLnRiLWltYWdlLWNhcHRpb24tZml0LXRvLWltYWdle2Rpc3BsYXk6dGFibGV9LnRiLWltYWdlIC50Yi1pbWFnZS1jYXB0aW9uLWZpdC10by1pbWFnZSAudGItaW1hZ2UtY2FwdGlvbntkaXNwbGF5OnRhYmxlLWNhcHRpb247Y2FwdGlvbi1zaWRlOmJvdHRvbX0gfSBAbWVkaWEgb25seSBzY3JlZW4gYW5kIChtYXgtd2lkdGg6IDU5OXB4KSB7ICAgIC50Yi1pbWFnZXtwb3NpdGlvbjpyZWxhdGl2ZTt0cmFuc2l0aW9uOnRyYW5zZm9ybSAwLjI1cyBlYXNlfS53cC1ibG9jay1pbWFnZSAudGItaW1hZ2UuYWxpZ25jZW50ZXJ7bWFyZ2luLWxlZnQ6YXV0bzttYXJnaW4tcmlnaHQ6YXV0b30udGItaW1hZ2UgaW1ne21heC13aWR0aDoxMDAlO2hlaWdodDphdXRvO3dpZHRoOmF1dG87dHJhbnNpdGlvbjp0cmFuc2Zvcm0gMC4yNXMgZWFzZX0udGItaW1hZ2UgLnRiLWltYWdlLWNhcHRpb24tZml0LXRvLWltYWdle2Rpc3BsYXk6dGFibGV9LnRiLWltYWdlIC50Yi1pbWFnZS1jYXB0aW9uLWZpdC10by1pbWFnZSAudGItaW1hZ2UtY2FwdGlvbntkaXNwbGF5OnRhYmxlLWNhcHRpb247Y2FwdGlvbi1zaWRlOmJvdHRvbX0gfSA=
Blog
Home Blog
[printfriendly]
LnRiLWZpZWxke21hcmdpbi1ib3R0b206MC43NmVtfS50Yi1maWVsZC0tbGVmdHt0ZXh0LWFsaWduOmxlZnR9LnRiLWZpZWxkLS1jZW50ZXJ7dGV4dC1hbGlnbjpjZW50ZXJ9LnRiLWZpZWxkLS1yaWdodHt0ZXh0LWFsaWduOnJpZ2h0fS50Yi1maWVsZF9fc2t5cGVfcHJldmlld3twYWRkaW5nOjEwcHggMjBweDtib3JkZXItcmFkaXVzOjNweDtjb2xvcjojZmZmO2JhY2tncm91bmQ6IzAwYWZlZTtkaXNwbGF5OmlubGluZS1ibG9ja311bC5nbGlkZV9fc2xpZGVze21hcmdpbjowfQ==
LnRiLWhlYWRpbmcuaGFzLWJhY2tncm91bmR7cGFkZGluZzowfQ==
- TGF0bzo3MDAjIyNQb3BwaW5zOjMwMA==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Sep 1, 2011
NeurogesX Submits Supplemental new Drug Application for Qutenza (R) 8% Patch for HIV-Associated Peripheral Neuropathy
Biopharmaceutical company, NeurogesX, announced it submitted a supplemental new drug to the US FDA seeking to expand the label to include an application for the management of pain due to… - TGF0bzo3MDAjIyNQb3BwaW5zOjMwMA==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Sep 1, 2011
Olive Leaf Extract May Help Fight Early-Diabetes Nerve Damage, Pain
At Kerman University of Medical Sciences in Kerman, Iran, researchers investigated the possible effects of olive leaf extract on in vitro and in vivo models of diabetic peripheral neuropathy. Their… -
Sep 1, 2011
U of M Earns $3 Million Grant to Develop Treatment for Nerve Damage
Univeristy of Michigan neurologist, David Fink, MD, leads the team studying treatment for nerve damage related to diabetes and chemotherapy. They will join Diamyd Inc. in a project funded by… -
Sep 1, 2011
Diamyd Gets $3M to Develop Treatment for Chemotherapy-Induced PN
Diamyd Medical and the University of Michigan have been awarded a $3M three-year NIH grant to develop a product for use in preventing chemo-induced neuropathy. The product could be administered… -
Sep 1, 2011
Conquer Cancer Foundation Presents Award to Dr. Schneider for his Research in Breast Cancer Patients
Dr. Bryan Schneider, MD, associate professor of medicine at Indiana University School of Medicine, was announced as the recipient of a $450,000 grant to further his research on the relationship… - TGF0bzo3MDAjIyNQb3BwaW5zOjMwMA==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Sep 1, 2011
Marijuana Extract Might Help Prevent Chemotherapy-Related Nerve Pain
Cannabidiol – a compound derived from marijuana – may be a promising new treatment to prevent the development of painful neuropathy in patients receiving the chemotherapy drug paclitaxel. These results… -
Sep 1, 2011
Chemotherapy-Induced Peripheral Neuropathy: A Debilitating Effect of Cancer
Colleen Erb, MSN, ACNP-BC, AOCNP, from Fox Chase Cancer Center writes about the debilitating effects of cancer treatments for patients – specifically peripheral neuropathy. Her article is in-depth and loaded… -
Aug 1, 2011
Rosiglitazone Investigated for Neuropathic Pain
The diabetes drug rosiglitazone (Avandia) is now being explored as a pain medication. The drug was initially controversial with some experts wanting to banish it and others wanting very tight…